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X-ray contrast angiography (CA) is the current
imaging modality of choice for endovascular proce-
dures. However, the iodinated contrast agent used is
directly responsible for systemic and renal adverse
effects,1 especially in elderly patients with comorbid
conditions, in 3% to 12% of the cases. As a result,
alternate imaging modalities have been explored.
Magnetic resonance angiography (MRA) has
been proposed as a valuable alternative to CA.2-4 It
provided results comparable to CA for imaging the
aortoiliac system and was superior for the distal vas-
culature.5,6 Using MRA to evaluate patients with
primary lower extremity occlusive disease proved to
be more cost-effective than CA.7 
Martin et al8 showed in an in vitro model that
intravascular ultrasound (IVUS) scan and MR images
correlate well with histologic findings in normal and
diseased arteries. In the endovascular field, Davis et
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Three stents were deployed within the aorta at the level of the renal arteries, and two
were deployed within the right iliac artery just below the aortic trifurcation. The aver-
age duration of the endovascular deployment was 13 minutes. There was an agreement
of 0.6 mm in the position of the stent as observed on iMR images and found at autop-
sy. When the piglets were sacrificed, the average distance between the stents and the pre-
defined target was 7.8 mm, mostly because of the migration of one stent. Axial views
allowed for accurate determination of stent impaction on the vascular wall. 
Conclusions: This study confirms the feasibility of stent deployment under near–real-time
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al,9 comparing MR angiography and CA of patients
before and after percutaneous transluminal angio-
plasty, demonstrated a high incidence of agreement
between the two techniques. They contend that the
excellent depiction of the morphologic changes
induced by percutaneous transluminal angioplasty
suggests great potential for the use of MR angio-
grams during interventional follow-up. Following a
study of 15 patients who received a nitinol-polyester
endoprosthesis, Engellau et al10 believe that MRA
provides the relevant information needed for their
adequate follow-up and that this may be the method
of choice because of its use of contrast media with
very low nephrotoxicity, lack of ionizing radiation,
and noninvasiveness.
More recent open-configuration or intervention-
al MR imaging (iMRI) systems provide direct access
to the patient, with the benefits of near–real-time
rendering. However, the previously mentioned ben-
efits observed with MRA will have to be demon-
strated on these iMRI systems.
Our preliminary studies in an in vitro model
indicated that iMRI has the potential to assist
endovascular manipulation with good image quality
and millimetric precision.11 The aim of the current
study is to assess the feasibility of insertion of
endovascular stents and the precision of an open-
field iMRI system in an in vivo model.
MATERIAL AND METHODS
Three male piglets with an average age of 6
months and a weight between 70 and 77 kg and two
3-month-old male piglets that weighed 40 to 44 kg
were used. The research protocol was approved by
the Institutional Animal Care Committee according
to the guidelines of the Canadian Council for
Animal Care. Animals intramuscularly received a
premedication composed of acepromazine, 0.2
mg/kg, butorphanol, 0.2 mg/kg, atropine, 0.05
mg/kg, and ketamine 10 mg/kg. Anesthesia was
maintained with an intravenous solution composed
of propofol, 1 mg/mL, ketamine, 1 mg/mL, fen-
tanyl, 0.4 mg/mL and diazepam, 0.05 mg/mL, at a
rate of 1.5 mL/kg per hour.
Magnetic resonance imaging. Imaging was per-
formed on an open-field 0.5T iMRI unit (SIGNA-SP;
General Electric Medical System, Milwaukee, Wis)
(Fig 1). A dedicated high-resolution near–real-time
imaging protocol was developed on this unit for
endovascular procedures. To that effect, we adopted a
fast two-dimensional gradient-recalled echo imaging
sequence with blood flow compensation, a 30-degree
flip angle, and a repetition time/echo-time of
13.2/44.9 ms along with a field of view of 34 × 34
cm2, sampled with a matrix of 512 (frequency) × 224
(phase) lines. The phase encoding direction was taken
parallel to the patient’s left/right axis to achieve sub-
millimetric resolution along the aorta while maintain-
ing an acceptable imaging speed. High resolution, 1
number of excitations, images were available every 10
seconds for accurate positioning of vascular stents.
Tracking at twice the image refresh rate (ie, one image
every 5 seconds) was also possible with a matrix of 256
× 160 lines. A long-lived blood pool MR contrast
agent was used (AngioMARK; EPIX Medical, Inc,
Cambridge, Mass) to facilitate visualization of the vas-
culature.12 AngioMARK (MS-325) is a new blood
pool MR contrast agent that binds reversibly to serum
Fig. 1. iMRI unit. The working area is shown by the long arrow.
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albumin in plasma. This is accomplished by the linkage
of a diphenylcyclohexyl group to a gadolinium chelate
through a phosphodiester bond.13 The reduction of
molecular tumbling rate of this chelate on binding to
serum albumin yielded relaxivities that are five to 10
times greater than that of gadopentetate dimeglumine
(Magnevist; Berlex, Wayne, NJ) over a range of mag-
netic field strengths and drug concentrations. In addi-
tion to primarily intravascular distribution, the binding
of AngioMARK to serum albumin also resulted in pro-
longed plasma half-life. Because of these properties
and favorable pharmacokinetics, AngioMARK (MS-
325) provides strong, persistent enhancement of
blood vessels on MRI scans.12 Early clinical data sug-
gest that intravenous administration of AngioMARK
was well tolerated in healthy volunteers and resulted in
selective and intense vascular enhancement over a 50-
minute period.14 This could be an advantage over
gadopentetate dimeglumine, which shows a rather
rapid enhancement loss within 15 minutes.15
Surgical procedure. After surgical exposure of
the right femoral artery and systemic hepariniza-
tion (100 IU/kg), an arteriotomy was performed.
A nitinol hydrophilic-coated guidewire (Glidewire;
Terumo, Somerset, NJ) was introduced into the
lumen of the vessel. A Memotherm Sixty 8 mm × 3
cm or × 4 cm iliac stent deployment system
(Angiomed; Bard, Karlsruhe, Germany) was intro-
Fig 2. Distance from the stent to the target at sacrifice: the accuracy of stent positioning by the oper-
ator ranges from 22 mm (stent that migrated) to 0 mm.
Fig 3. Difference between iMRI and sacrifice assessment of stent position in relation to the target. The
mean iMRI accuracy averages 0.6 mm.
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duced into the femoral artery over the guidewire
and positioned a few centimeters beyond the arte-
riotomy. The piglet was then transferred to the
iMR system and placed in the supine position. The
abdominal wall was then covered by a rectangular
transmit/receive linear surface coil for MRI.
Imaging of the abdominal vascular system was
first achieved through maximum intensity projec-
tions (MIPs), to accurately visualize and localize the
predefined target. The latter was located within the
aorta, at the level of the lowest renal artery, or in the
right iliac artery, at the aortic trifurcation. Then,
with the high-resolution–dedicated, near–real-time
MR sequence, a permanent cursor was positioned in
less than 1 minute onto the MR image, at the target,
as a landmark for the operator during the procedure.
The stent was guided through the arterial system
until its proximal marker reached the cursor. The
stent was then deployed by the operator onto the
target. Once the stent deployment system was
removed, the position of the stent was assessed with
coronal, axial, and sagittal views. Finally, the distance
between the proximal extremity of the stent and the
target on the MR screen was measured. The other
variable assessed was the duration of the MR-guided
procedure, from the beginning of the stent position-
ing to the end of the deployment.
The animal was then sacrificed with sodium pen-
tobarbital (100 mg/kg, intravascularly) after
removal of the guidewire. At autopsy the position of
the stent in relation to the target was measured with
a millimetric ruler.
RESULTS
Two stents were deployed in the right iliac artery
below the aortic trifurcation, and the three others
were deployed in the abdominal aorta at the level of
the renal arteries. The initial preparation of the ani-
mal on the iMRI system, as well as scout imaging to
localize anatomic landmarks, took roughly 20 min-
utes. The mean duration of the procedure from the
beginning of positioning, starting in the distal iliac
artery, to the end of deployment was 13 minutes
(range, 12-15 minutes). On average, the end posi-
tion of the stent was found to be 7.8 mm (range, 0-
22 mm) away from the target. This is largely due to
one migration of an aortic stent, which occurred
because of a mismatch in diameter with the aorta.
This migration was immediately detected with the
near–real-time MRI system. This stent was 22 mm
away from its target. Excluding this migration, the
average distance between the end position of the
stent and its target was 4.25 mm (range, 0-9 mm)
(Fig 2). The iMRI positioning accuracy, or the dif-
ference between the stent location as assessed with
MR images and autopsy was found to be 0.6 mm
(range, 0-2 mm) (Fig 3). This accuracy of the iMRI
system in confirming the final stent position is well
demonstrated when intraoperative MR images pro-
vided by the iMRI and those from the autopsy are
compared (Fig 4). Axial and sagittal views were
helpful in the assessment of stent position (Fig 5).
Fig 4. Comparison between the iMR image of an iliac
stent and the autopsy finding. A, The proximal extremity
of the stent is positioned immediately below the aortic tri-
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DISCUSSION
Our study demonstrates the feasibility of insertion
of endovascular stents and the precision of the open-
field iMRI system. The near–real-time guidance pro-
vided by the open-configuration MRI system allowed
us to position and to deploy the stents onto a prede-
fined target in 13 minutes. The distance of the stent to
the target decreased during the course of the study
from 22 mm, when the stent migrated, to 0 mm and
was due to increasing operator ability to interpret the
images from the system liquid crystal display monitors
(Fig 2). The markers on the delivery system create arti-
facts at each end of the stent, which we learned to eval-
uate by taking the midpoint of the artifact as the refer-
ence point. As mentioned below, this is one of the
issues that should be addressed to optimize endovas-
cular devices for MR compatibility. This study con-
firms that the accuracy of measurements with the
iMRI system averaged 0.6 mm (Fig 3). The iMRI
measures for comparison with autopsy findings were
taken on the main console after the introducing sheath
had been removed, thus eliminating the previously
mentioned potential artifactual error from calculation.
Our experimental model does not entirely reflect
reality from a clinical standpoint. Before we used the
pig model, we evaluated the ability to track a
catheter up to the renal arteries in two dogs. In the
second animal, we deployed a balloon angioplasty
catheter. Fig 6 shows the dog aorta in the coronal
(A, C) and axial (B, D) planes, before (A, B) and at
the end (C, D) of balloon dilatation (Blue Max, 4
cm × 9 mm; Medi-Tech, Boston Scientific Corp,
Watertown, Mass). Because no contrast material was
used, blood flow within the aorta is less well per-
ceived. Furthermore, saline was injected into the
balloon instead of contrast material. Nevertheless,
blood flow can be seen around the catheter in Fig 6
(A, B), whereas only saline that shows as a darker
material than blood is visualized in the dilated bal-
loon in Fig 6 (C, D).
Before the current study, we planned to use stents
8 mm in diameter because we have a large experience
in laparoscopic replacement of the infrarenal aorta of
70-kg piglets with 6-mm grafts. However, a clamped
aorta contracted, and we noticed during evaluation
of the first piglet’s aorta under iMRI that the
unclamped aorta actually measured 12 mm in diam-
eter. We chose to insert the 8-mm stent in this aorta
because, to our knowledge, there was no description
of an inadequate stent impaction imaged under iMRI
(Fig 5, A). We could follow its migration and evalu-
ate the stent position inside the artery as well as the
flow both inside and outside the stent. Our results
show that the different sizes of the piglets did not
influence the quality of visualization of the aortoiliac
segment. The iliac stents were placed in the 70-kg
piglets, and the last two 8-mm aortic stents were
placed in the 40-kg piglets. 
For aortic endografting, three different image
modalities are suggested: computed tomographic
(CT) scan, CA, and IVUS scan. MRA is a technique
capable of providing as reliable an imaging of the vas-
cular system as CA, without any magnification, throm-
bus effects, parallax, and projection errors. It could
also advantageously replace the CT scan for measure-
ment of the aneurysm diameter and produce three-
dimensional (3-D) reconstruction of the aorta.16 Axial
views have been shown to provide information similar
to IVUS scan.7
Fig 5. Examples of views and resolutions obtainable with
the iMRI system. A, Low resolution image, in the axial
plane, rapidly acquired, demonstrating the stent as a black
ring (long arrow), which does not impact on the right side
of the aortic wall (arrowhead). Flow can be seen within the
stent. The guidewire is also visible in the stent (short
arrow). The vena cava can be seen to the right of the
aorta. B, At a higher resolution, the stent is well seen with-
in the aorta in the sagittal plane.
A
B
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 5 Dion et al 1011
In 1998, we initiated our iMRI vascular program
on premises identical to those previously described.
However, definite confirmation of the potential of
the iMRI systems will need further research.
Despite the promises expected from this new
imaging modality, a number of questions have to be
answered before it becomes suitable for endovascular
surgery. The refresh rate of 5 to 10 seconds is too
slow for clinical application. This limited imaging rate
resulted from our requirements for sufficient posi-
tional resolution and good vessel/lumen contrast.
We found that the maximum rate of one image every
2 seconds, which is possible with our iMRI system,
could not be exploited without compromising good
visualization of the vasculature. This limitation of
current iMRI systems is to be addressed by the man-
ufacturers in the near future with open-configuration
magnets having stronger magnetic fields and faster
gradient slew rates. For instance, General Electric
Medical Systems recently introduced a new open-
configuration magnet (OpenSeed) with a 0.7 T field.
Research on current iMRI systems focuses on
developing peripheral software and hardware technol-
ogy that will ultimately allow real-time imaging.16 In
an in vitro model imaged by a similar iMRI unit as
ours, Zimmermann et al17 showed that active MR
tracking could allow 10 positional updates per second.
In comparison to the passive tracking technique
we adopted in our study, active MR tracking implies
the use of a miniature coil acting as a transmit/receive
radio-frequency–antenna sensitive to the MR signal in
its immediate vicinity. The MR imaging slice can be
further constrained to the tip of the active device,
which greatly facilitates navigation through tortuous
vessels while imaging. However, such coils18,19 bring
about engineering challenges pertaining to (1) their
integration to the appropriate endovascular device for
the targeted procedure without affecting its steerabil-
ity, (2) hardware and software integration to the MR
imager itself, and (3) biosafety regulations.
Fig 6. A dog aorta seen in the coronal (A, C) and axial (B, D) planes, before (A, B) and at the end
(C, D) of balloon dilatation. A, The portion of the angioplasty catheter (long arrow) lying between
the two markers (arrowheads) is seen. The markers create significant artifacts at the midportion that
represent the true center of the marker. The left renal artery is seen (short arrow). The right renal artery
is also visible (dashed arrow). The distal aorta and iliac arteries are not visualized with this coronal sec-
tion. B, The angioplasty catheter (short arrow) is visualized in the middle of the aorta (small arrow-
heads). The vena cava (long arrow) lies to the right of the aorta in these sequences. C, The 4-cm long
(from one marker to the other [short arrows]) angioplasty balloon dilates the aorta (arrowheads). D,
The aorta (small arrows) is being dilated by the balloon in which saline has been introduced. The bal-
loon totally fills the aortic lumen. 
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Regardless of the open-configuration MRI sys-
tem used, tracking within the vascular system needs
improvement. Certainly, the iliac vessels of the piglets
are straight and free of disease, and one could antici-
pate some difficulties when tortuous and atheroma-
tous human iliac arteries will need to be negotiated.
To address this issue, we are currently developing a
road map technique in an in vitro model. The image
of the endovascular device could then be superposed
on the road map and visualized at all times during the
procedure.20 Fig 7, A, shows a picture of the in vitro
model simulating a tortuous iliac artery. Fig 7, B,
demonstrates reconstruction of the model by means
of MIP, which will be used as a road map. This MIP
is exactly 29 cm long and corresponds perfectly to
the model dimensions as well as its maximum height,
which is 10 cm. Fig 7, C, shows a sequence of
near–real-time catheter tracking. The 4-cm long, 7-
mm wide balloon of the catheter (Marshal; Medi-
Tech, Boston Scientific Corp) is seen in black,
because air was injected in the balloon. For the exact
position of the balloon in the model to be seen, this
sequence has to be superposed on the road map (Fig
7, D). As a result, we have been able to follow
through the entire model the catheter progression in
near–real-time mode. The kink made in the tubing
(Fig 7, A, short arrow,) is also visualized as a “steno-
sis” on the other iMR images (short arrow).
Fig 7. The in vitro model. Corresponding lengths of the model and MIP (29 cm) are delimited by
arrowheads on each picture. The maximum height of the model is 10 cm. A, In vitro model simulat-
ing a tortuous iliac artery. B, iMRI reconstruction of the model with the use of MIP as road map. C,
Sequence of near–real-time catheter tracking. The balloon of the catheter is visible because it has been
filled with air. D, Superposition of C on B provides the equivalent of making a road map in near–real-
time. The balloon is visible in exactly the same location as in C. The kink made in the tubing (short
arrow, A) is also visualized as a “stenosis” on the other iMRI images (short arrow).
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Another shortcoming of MR systems is that all
instrumentation should be made of MR compatible
material such as plastic, titanium, glass, and fiberop-
tic or copper alloys. Any instrument containing steel
is prohibited in the magnet room. However, MR-
compatible surgical instrumentation, such as for-
ceps, scissors, and knives, is available. Material for
general anesthesia (such as respirators) is also avail-
able. Shellock21 published a pocket guide to MR
procedures and metallic objects. It contains infor-
mation about numerous materials from intravascular
coils, filters, and stents to heart valves, orthopedic
and otologic implants.
Patients who have pacemakers, who have claustro-
phobia, who have undergone recent surgery where
metallic clips have been used, or who have any metal-
lic implants are denied access to this technology. For
endovascular techniques, modifications to available
materials will be necessary. For instance, present
markers cause artifacts that can lead to error in posi-
tioning or in the evaluation of the arterial lumen.22
Devices made with nitinol are MR compatible. We
have evaluated Bard nitinol stents and the Boston
Scientific Passager endovascular graft; they demon-
strate MR compatibility. We also found the Terumo
nitinol glidewire MR compatible. Hilfiker et al22 stud-
ied some plain and covered stent grafts. They con-
clude that the ability to evaluate stents with contrast
3-D MR angiography depends on the type of stent.
They further add that, provided nitinol-based uncov-
ered or covered stents are used, 3-D MR angiography
may be considered an attractive alternative to digital
subtraction angiography, ultrasound scan, or CT
angiography for assessing the stent lumen. 
As mentioned previously, we prefer passive track-
ing, which generally exploits the physical properties
of materials from which endovascular devices are
produced, to generate sharp local variations in the
MR image at their location. With this tracking
modality, other imaging avenues are possible.
Coating the surface or filling the inner volume23 of
guidewires, catheters, or balloons with compounds
that generate hyperintense MR signals would enable
their visualization. Also, vascular flow can be imaged
with high MR signal when blood pool–specific
gadolinium chelates are used.
In summary, our study confirmed the feasibility
and the reliability of endovascular stenting under the
guidance of an iMRI system. The refinement of the
technique, with the availability of new software and
hardware, could make the iMRI a valuable comple-
ment or alternative to the current imaging modali-
ties for endovascular procedures.
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